- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 928234, 10 pages
The Effects of Jiang-Zhi-Ning and Its Main Components on Cholesterol Metabolism
1Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chao Yang District, Beijing 100029, China
2Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16 Nanxiaojie, Dongzhimennei, Beijing 100700, China
3Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China
Received 13 November 2011; Revised 24 February 2012; Accepted 25 February 2012
Academic Editor: Keji Chen
Copyright © 2012 Jianxin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Blankstein, M. J. Budoff, L. J. Shaw, and al. et, “Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis),” Journal of the American College of Cardiology, vol. 58, no. 4, pp. 364–374, 2011.
- A. M. Gotto, “Lipid lowering, regression, and coronary events: a review of the interdisciplinary council on lipids and cardiovascular risk intervention, seventh council meeting,” Circulation, vol. 92, no. 3, pp. 646–656, 1995.
- Y. Osono, L. A. Woollett, J. Herz, and J. M. Dietschy, “Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse,” Journal of Clinical Investigation, vol. 95, no. 3, pp. 1124–1132, 1995.
- T. Kobayashi, T. Ito, and M. Shiomi, “Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 406473, 10 pages, 2011.
- R. Huijgen, M. N. Vissers, I. Kindt, et al., “Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the LDL-receptor or apolipoprotein B genes,” Circulation: Cardiovascular Genetics, vol. 4, no. 4, pp. 413–417, 2011.
- M. Kawasaki, Y. Miura, R. Funabiki, et al., “Comparison of the effects on lipid metabolism of dietary methionine and cystine between hepatoma-bearing and normal rats,” Bioscience, Biotechnology, and Biochemistry, vol. 74, no. 1, pp. 158–167, 2010.
- C. R. Pullinger, C. Eng, G. Salen et al., “Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype,” Journal of Clinical Investigation, vol. 110, no. 1, pp. 109–117, 2002.
- E. P. Ratliff, A. Gutierrez, and R. A. Davis, “Transgenic expression of CYP7A1 in ldl receptor-deficient mice blocks diet-induced hypercholesterolemia,” Journal of Lipid Research, vol. 47, no. 7, pp. 1513–1520, 2006.
- I. Björkhem, Z. Araya, M. Rudling, B. Angelin, C. Einarsson, and K. Wikvall, “Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. no coordinate regulation of CYP7A1 and CYP27A1,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 26804–26807, 2002.
- L. J. Wilcox, N. M. Borradaile, L. E. De Dreu, and M. W. Huff, “Secretion of hepatocyte apob is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP,” Journal of Lipid Research, vol. 42, no. 5, pp. 725–734, 2001.
- J. H. Guan, Z. Xue, and J. B. Ren, “Experimental research on the fat-rculating and anti-atheroscleorsis effect of JiangZhiNing,” Pharmacology and Clinics of Chinese Materia Medica, vol. 17, no. 4, pp. 29–30, 2001.
- X. Han, C. A. Wu, and W. Wang, “Mechanism research of stilbene glucoside from polygonum multiflovum thunb on hyperlipemia,” Chinese Archives of Traditional Chinese Medicine, vol. 26, no. 6, pp. 1687–1689, 2008.
- D. Huang and Y. G. Shi, “Interventional effects of hawthorn, konjac and their compound on the levels of lipid and NO in plasma of rats being induced to hyperlipidemia,” Acta Academiae Medicinae Militaris Tertiae, vol. 27, no. 13, pp. 1361–1363, 2005.
- R. Zhang, M. L. Feng, and Y. P. Wu, “Experimental study on the active situs of fetid cassia seed to reduce blood lipid and their dose-effect relation,” Chinese Remedies & Clinics, vol. 5, no. 3, pp. 183–185, 2005.
- X. Y. Yang, Y. P. Zhou, and L. G. Dai, “Antilipemic effect of extracts of ampelopis grossedentata and lotus leaf (EAGLL) on rats with hypercholesterolemia,” Chinese Journal of Laboratory Animal Science, vol. 15, no. 3, pp. 281–284, 2005.
- W. Peeters, F. L. Moll, and A. Vink, “Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome,” European Heart Journal, vol. 32, no. 18, pp. 2314–2325, 2011.
- C. A. Bursill and P. D. Roach, “Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells,” Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1621–1626, 2006.
- W. L. Zhang, D. W. Liu, X. D. Wo, Y. H. Zhang, M. M. Jin, and Z. S. Ding, “Effects of curcuma longa on proliferation of cultured bovine smooth muscle cells and on expression of low density lipoprotein receptor in cells,” Chinese Medical Journal, vol. 112, no. 4, pp. 308–311, 1999.
- J. Li, L. Yu, N. Li, and H. Wang, “Astragalus mongholicus and angelica sinensis compound alleviates nephrotic hyperlipidemia in rats,” Chinese Medical Journal, vol. 113, no. 4, pp. 310–314, 2000.
- M. J. Mao, J. P. Hu, F. R. Chen, Y. Y. Zhang, and P. Liu, “Effects of chinese herbal medicine guanxinkang on lipid metabolism and serum c-reactive protein, amyloid a protein and fibrinogen in apolipoprotein e-knockout mice with atherosclerosis,” Journal of Chinese Integrative Medicine, vol. 9, no. 3, pp. 306–312, 2011.
- X. l. Wang, H. X. Zhang, Y. Z. Lu, and Y. C. Fan, “Effects of Tiaogandaozhuo Decoction on the Liver’s lipid content of rabbit with experimental atherosclerosis and the Lipoprotein Receptor in the Hepatocyte Membrane Vultured in Vitro,” Chinese Journal of Traditional Medical Science and Technology, vol. 9, no. 4, pp. 208–210, 2002 (Chinese).
- P. Y. Yang, M. R. Almofti, L. Lu et al., “Reduction of atherosclerosis in cholesterol-fed rabbits and decrease of expressions of intracellular adhesion molecule-1 and vascular endothelial growth factor in foam cells by a water-soluble fraction of polygonum multiflorum,” Journal of Pharmacological Sciences, vol. 99, no. 3, pp. 294–300, 2005.
- W. Xie, C. Sun, and S. Liu, “Effect of hawthorn flavanone on blood-fat and expression of lipogenesis and lipolysis genes of hyperlipoidemia model mouse,” Zhongguo Zhongyao Zazhi, vol. 34, no. 2, pp. 224–229, 2009.
- H. B. Li, K. Y. Fang, C. T. Lü, and X. E. Li, “Study on lipid-regulating function for the extracts and their prescriptions from semen cassiae and fructus crataegi,” Zhong Yao Cai, vol. 30, no. 5, pp. 573–575, 2007.
- G. Ryu, J. H. Ju, V. J. Park, et al., “The radical scavenging effects of stilbene glycosides from poygonum multiflorum,” Archives of Pharmacal Research, vol. 25, no. 5, pp. 636–639, 2002.
- L. Lv, X. Gu, J. Tang, and C. T. Ho, “Antioxidant activity of stilbene glycoside from Polygonum multiflorum Thunb in vivo,” Food Chemistry, vol. 104, no. 4, pp. 1678–1681, 2007.
- K. L. Da Silva, A. R. S. Dos Santos, P. E. O. Mattos, R. A. Yunes, F. Delle-Monache, and V. Cechinel-Filho, “Chemical composition and analgesic activity of calophyllum brasiliense leaves,” Therapie, no. 4, pp. 431–434, 2001.
- Y. L. Lu, Y. Q. He, M. Wang et al., “Characterization of nuciferine metabolism by p450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals,” Acta Pharmacologica Sinica, vol. 31, no. 12, pp. 1635–1642, 2010.
- Z. Wu, L. J. Wu, S. Tashiro, S. Onodera, and T. Ikejima, “Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonin-induced hela cell apoptosis,” Chinese Medical Journal, vol. 118, no. 8, pp. 671–677, 2005.
- A. J. Tremblay, B. Lamarche, V. Lemelin et al., “Atorvastatin increases intestinal expression of npc1l1 in hyperlipidemic men,” Journal of Lipid Research, vol. 52, no. 3, pp. 558–565, 2011.
- J. Y. L. Chiang, R. Kimmel, and D. Stroup, “Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (lxrα),” Gene, vol. 262, no. 1-2, pp. 257–265, 2001.
- S. Gupta, W. M. Pandak, and P. B. Hylemon, “LXR alpha is the dominant regulator of CYP7A1 transcription,” Biochemical and Biophysical Research Communications, vol. 293, no. 1, pp. 338–343, 2002.
- Y. Luo and A. R. Tall, “Sterol upregulation of human cetp expression in vitro and in transgenic mice by an lxr element,” Journal of Clinical Investigation, vol. 105, no. 4, pp. 513–520, 2000.